Published in Cephalalgia on June 01, 1996
Cognitive-behavioral group treatment for disabling headache. Pain Med (2004) 1.54
A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings. BMC Neurol (2011) 1.21
Psychological risk factors in headache. Headache (2007) 1.10
Secular changes in health care utilization and work absence for migraine and tension-type headache: a population based study. Eur J Epidemiol (2005) 1.09
Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine. Cephalalgia (2010) 1.06
Perceptions and needs of patients with migraine: a focus group study. J Fam Pract (2002) 1.05
Real-time sharing and expression of migraine headache suffering on Twitter: a cross-sectional infodemiology study. J Med Internet Res (2014) 1.03
Feasibility assessment of telephone-administered behavioral treatment for adolescent migraine. Headache (2007) 0.98
Migraine education improves quality of life in a primary care setting. Headache (2010) 0.92
Acute treatment of migraine. Breaking the paradigm of monotherapy. BMC Neurol (2004) 0.90
The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research. Mayo Clin Proc (2009) 0.90
Acute migraine: Current treatment and emerging therapies. Ther Clin Risk Manag (2007) 0.87
Experiences and perceptions of people with headache: a qualitative study. BMC Fam Pract (2006) 0.87
The use of combination therapies in the acute management of migraine. Neuropsychiatr Dis Treat (2006) 0.82
Quality of life and migraine disability among female migraine patients in a tertiary hospital in Malaysia. Biomed Res Int (2015) 0.82
Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache (2016) 0.81
The associations of migraines and other headaches with work performance: results from the National Comorbidity Survey Replication (NCS-R). Cephalalgia (2010) 0.80
Reliability and validity of the migraine disability assessment scale among migraine and tension type headache in Iranian patients. Biomed Res Int (2014) 0.80
The Impact of Post-Traumatic Stress Disorder on the Burden of Migraine: Results From the National Comorbidity Survey-Replication. Headache (2015) 0.78
Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal. Drug Des Devel Ther (2010) 0.77
Validity and reliability of the Bahasa Melayu version of the Migraine Disability Assessment questionnaire. Biomed Res Int (2014) 0.76
Taking the headache out of migraine. Neurol Clin Pract (2015) 0.75
Health care utilization and changes in health status over time for migraineurs. Pain Res Manag (2007) 0.75
Lysine clonixinate vs naproxen sodium for the acute treatment of migraine: a double-blind, randomized, crossover study. MedGenMed (2005) 0.75
Intravenous lysine clonixinate for the acute treatment of severe migraine attacks: a double-blind, randomized, placebo-controlled study. Curr Ther Res Clin Exp (2003) 0.75
Migraine in men: fact sheet. A publication to mark European Migraine Day of Action 2014. Funct Neurol (2014) 0.75
The presenting and prescribing patterns of migraine in an Australian emergency department: A descriptive exploratory study. World J Emerg Med (2017) 0.75
A physical map of 30,000 human genes. Science (1998) 12.43
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (2001) 6.61
New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97
Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA (1992) 4.77
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia (2010) 4.24
Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect Immun (1998) 4.19
Risk of Alzheimer's disease and duration of NSAID use. Neurology (1997) 4.06
Screening for dementia with the memory impairment screen. Neurology (1999) 3.92
Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest (1984) 3.86
Competence for genetic transformation in encapsulated strains of Streptococcus pneumoniae: two allelic variants of the peptide pheromone. J Bacteriol (1996) 3.72
Clinical and prognostic subforms of new daily-persistent headache. Neurology (2010) 3.60
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia (2010) 3.54
Retrovirus genomes methylated by mammalian but not bacterial methylase are non-infectious. Nature (1983) 3.43
Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia (2000) 3.32
Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci U S A (1998) 3.17
Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology (1996) 3.15
Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet (2001) 3.10
Burden of migraine in the United States: disability and economic costs. Arch Intern Med (1999) 3.05
A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease. Stat Med (2000) 2.90
The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia (2003) 2.87
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia (2005) 2.86
Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology (1994) 2.84
Prevalence of frequent headache in a population sample. Headache (2004) 2.82
Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain (2003) 2.79
Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia (2002) 2.78
High-efficiency transformation of Streptococcus lactis protoplasts by plasmid DNA. Appl Environ Microbiol (1986) 2.68
Epidemiology of tension-type headache. JAMA (1998) 2.63
Pax: a murine multigene family of paired box-containing genes. Genomics (1991) 2.60
Memory impairment on free and cued selective reminding predicts dementia. Neurology (2000) 2.58
Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry (2010) 2.57
Leisure activities and the risk of amnestic mild cognitive impairment in the elderly. Neurology (2006) 2.51
Migraine and cardiovascular disease: a population-based study. Neurology (2010) 2.51
Migraine in adolescents: association with socioeconomic status and family history. Neurology (2007) 2.46
Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology (2001) 2.43
Global prevalence of chronic migraine: a systematic review. Cephalalgia (2010) 2.43
Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland. Development (1990) 2.42
Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain (2000) 2.41
Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia (2010) 2.35
The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians. Arch Neurol (2000) 2.35
A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology (2005) 2.34
Low blood pressure and the risk of dementia in very old individuals. Neurology (2003) 2.30
Chagas' disease. Clin Microbiol Rev (1992) 2.30
Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol (1999) 2.30
Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology (2001) 2.29
Hemicrania continua: ten new cases and a review of the literature. Neurology (1994) 2.26
Timing fracture repair in patients with severe brain injury (Glasgow Coma Scale score <9) J Trauma (1998) 2.24
A single dominant gene can account for eye tracking dysfunctions and schizophrenia in offspring of discordant twins. Arch Gen Psychiatry (1988) 2.21
Transient and restricted expression during mouse embryogenesis of Dll1, a murine gene closely related to Drosophila Delta. Development (1995) 2.20
Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia (2010) 2.18
A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain (1997) 2.16
Memory and mental status correlates of modified Braak staging. Neurobiol Aging (2000) 2.15
Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology (2003) 2.14
Maternal inhibition of hepatitis B surface antigen gene expression in transgenic mice correlates with de novo methylation. Nature (1987) 2.00
Medical consultation for migraine: results from the American Migraine Study. Headache (1998) 1.99
Headache and major depression: is the association specific to migraine? Neurology (2000) 1.91
An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology (1999) 1.89
Education delays accelerated decline on a memory test in persons who develop dementia. Neurology (2007) 1.87
Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia (2008) 1.83
Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia (1999) 1.82
Premonitory symptoms in migraine: an electronic diary study. Neurology (2003) 1.81
Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol (2012) 1.77
Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther (2000) 1.76
Phase I clinical and pharmacokinetic study of taxol. Cancer Res (1987) 1.74
Cumulative lifetime migraine incidence in women and men. Cephalalgia (2008) 1.73
The effects of preclinical dementia on estimates of normal cognitive functioning in aging. J Gerontol B Psychol Sci Soc Sci (1996) 1.73
Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol (1993) 1.70
Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology (1999) 1.70
Proposals for new standardized general diagnostic criteria for the secondary headaches. Cephalalgia (2009) 1.68
A mouse gene homologous to the Drosophila gene caudal is expressed in epithelial cells from the embryonic intestine. Genes Dev (1988) 1.68
Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology (2011) 1.67
Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology (2008) 1.66
Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology (2007) 1.64
Pediatric migraine and the International Headache Society (IHS) criteria. Neurology (1997) 1.63
Sodium di-N-propylacetate (DPA) in the treatment of epilepsy. A review. Epilepsia (1975) 1.63
Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache (1994) 1.59
A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology (1998) 1.57
Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology (2011) 1.57
Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia (2010) 1.56
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy (2006) 1.55
A genotype of exceptional longevity is associated with preservation of cognitive function. Neurology (2006) 1.54
Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey. Urology (2001) 1.53
Genes for skeletal muscle myosin heavy chains are clustered and are not located on the same mouse chromosome as a cardiac myosin heavy chain gene. Proc Natl Acad Sci U S A (1985) 1.51
Cognitive activities delay onset of memory decline in persons who develop dementia. Neurology (2009) 1.51
Leg ulcer care: an audit of cost-effectiveness. Health Trends (1996) 1.51
Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers. Neurology (1999) 1.51
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol (2012) 1.49
Comorbidity of migraine and epilepsy. Neurology (1994) 1.46
Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. Am J Epidemiol (2001) 1.46
Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy (2012) 1.46
Key priorities in managing glucose control in older people with diabetes. J Nutr Health Aging (2009) 1.45
DNA-methylase from regenerating rat liver: purification and characterisation. Nucleic Acids Res (1978) 1.44
Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma. J Clin Oncol (1987) 1.44
Seronegative chronic relapsing neuroborreliosis. Eur Neurol (1995) 1.43
Apoplectic headache and oculomotor nerve palsy: an unusual presentation of multiple sclerosis. Neurology (1990) 1.43
Variation in migraine prevalence by race. Neurology (1996) 1.42
The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy (2004) 1.42
Hemicrania continua: attacks may alternate sides. Headache (1992) 1.41
Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated. Cephalalgia (1993) 1.41